Who owns Silence Therapeutics plc?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SLN from SEC Form 13F filings across 92 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 92 institutions disclosed 48.3M shares of Silence Therapeutics plc worth $513.1M — about 87.4% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
92
13F holders
$513.1M
value, 2026 filers
87.4%
of shares outstanding (48.3M sh)
34
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SLN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLCNEW | 4.7M | $51.5M | 0.0% | 8.5% | new |
| 2 | Siren, L.L.C. | 2.9M | $31.6M | 0.7% | 5.2% | -12.8% |
| 3 | CITADEL ADVISORS LLC | 2.8M | $30.9M | 0.0% | 5.1% | +112.5% |
| 4 | Redmile Group, LLC | 2.5M | $26.9M | 2.0% | 4.5% | +13.7% |
| 5 | Tetragon Partners GP Ltd | 2.4M | $26.6M | 3.5% | 4.4% | +218.7% |
| 6 | Soleus Capital Management, L.P. | 2.4M | $26.1M | 0.9% | 4.3% | +278.7% |
| 7 | Balyasny Asset Management L.P. | 2.3M | $24.6M | 0.0% | 4.1% | +269.0% |
| 8 | Squadron Capital Management LLCNEW | 2.1M | $22.8M | 5.7% | 3.8% | new |
| 9 | TCG Crossover Management, LLC | 1.8M | $19.9M | 0.6% | 3.3% | -40.0% |
| 10 | MORGAN STANLEY | 1.8M | $19.2M | 0.0% | 3.2% | +336.8% |
| 11 | Nextech Invest Ltd. | 1.7M | $18.5M | 0.8% | 3.1% | +77.8% |
| 12 | MILLENNIUM MANAGEMENT LLC | 1.5M | $15.9M | 0.0% | 2.6% | +59.9% |
| 13 | BNP PARIBAS FINANCIAL MARKETS | 1.2M | $12.8M | 0.0% | 2.1% | +638.0% |
| 14 | Nantahala Capital Management, LLC | 1.2M | $12.7M | 0.4% | 2.1% | -13.7% |
| 15 | Qube Research & Technologies Ltd | 1.1M | $11.6M | 0.0% | 1.9% | +545.9% |
| 16 | AMERIPRISE FINANCIAL INC | 1.0M | $11.3M | 0.0% | 1.9% | +180.6% |
| 17 | Ikarian Capital, LLC | 821,790 | $3.3M | 0.3% | 1.5% | -1.1% |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 820,638 | $9.0M | 0.0% | 1.5% | +344.7% |
| 19 | Persistent Asset Partners Ltd | 781,965 | $781,965 | 0.2% | 1.4% | +5054.7% |
| 20 | MONTANOVA CAPITAL, LLCNEW | 740,740 | $8.1M | 0.2% | 1.3% | new |
| 21 | RTW INVESTMENTS, LPNEW | 700,000 | $7.7M | 0.1% | 1.3% | new |
| 22 | KVP Capital Advisors, LPNEW | 684,123 | $7.5M | 6.0% | 1.2% | new |
| 23 | TWO SIGMA INVESTMENTS, LP | 679,702 | $7.4M | 0.0% | 1.2% | +461.7% |
| 24 | ADAR1 Capital Management, LLC | 629,654 | $6.9M | 0.3% | 1.1% | +86.1% |
| 25 | UBS Group AG | 609,678 | $6.7M | 0.0% | 1.1% | +150.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.